153 related articles for article (PubMed ID: 33085553)
1. Feasibility of p16 surrogate biomarker as adjunct diagnosis of oral and oropharyngeal malignancy in a resource-constrained country.
Adham M; Aldino N; Zahra S; Rachmadi L; Bardosono S
Acta Otolaryngol; 2021 Jan; 141(1):106-110. PubMed ID: 33085553
[TBL] [Abstract][Full Text] [Related]
2. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma.
Wilson BL; Israel AK; Ettel MG; Lott Limbach AA
J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829
[TBL] [Abstract][Full Text] [Related]
3. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
4. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
[TBL] [Abstract][Full Text] [Related]
5. p16 immunostaining in fine-needle aspirations of the head and neck: determining the optimal positivity threshold in HPV-related squamous cell cancer.
Wang Q; Zhou F; Snow JT; Simsir A; Hernandez O; Levine P; Szeto O; Sun W; Givi B; Brandler TC
J Am Soc Cytopathol; 2021; 10(6):592-600. PubMed ID: 34326027
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
[TBL] [Abstract][Full Text] [Related]
7. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Wong KS; Krane JF; Jo VY
Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
[TBL] [Abstract][Full Text] [Related]
9. HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.
Toman J; Von Larson S; Umeno H; Kurita T; Furusaka T; Hasegawa H; Prasad ML; Sasaki CT
Ann Otol Rhinol Laryngol; 2017 Feb; 126(2):152-158. PubMed ID: 27913709
[TBL] [Abstract][Full Text] [Related]
10. HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping?
Orsaria M; Marzinotto S; De Marchi L; Giacomarra V; Boria S; Rubini C; Londero AP; Di Loreto C; Mariuzzi L
Anticancer Res; 2015 Sep; 35(9):4733-9. PubMed ID: 26254363
[TBL] [Abstract][Full Text] [Related]
11. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.
Abi-Raad R; Prasad ML; Gilani S; Garritano J; Barlow D; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):394-404. PubMed ID: 33369885
[TBL] [Abstract][Full Text] [Related]
13. Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs.
Isaac A; Kostiuk M; Zhang H; Lindsay C; Makki F; O'Connell DA; Harris JR; Cote DW; Seikaly H; Biron VL
J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):5. PubMed ID: 28088212
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
15. p16 immunohistochemistry for primary tumor detection in HPV-positive squamous cell carcinoma of unknown primary.
Shan A; Rooper LM; Ryan JF; Eisele DW; Fakhry C
Am J Otolaryngol; 2021; 42(5):103015. PubMed ID: 33857776
[TBL] [Abstract][Full Text] [Related]
16. Sexual behaviour, HPV status and p16
Emmett S; Boros S; Whiteman DC; Porceddu SV; Panizza BJ; Antonsson A
J Gen Virol; 2018 Jun; 99(6):783-789. PubMed ID: 29708483
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
18. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
19. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
20. Current Status of p16 Immunohistochemistry and HPV Testing in Fine Needle Aspiration Specimens of the Head and Neck.
Jalaly JB; Hosseini SM; Shafique K; Baloch ZW
Acta Cytol; 2020; 64(1-2):30-39. PubMed ID: 30783052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
